SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Vardhaman Laboratories Ltd (524796)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524796 NSE: Pharmaceuticals & Drugs | Small Cap | Vardhaman Lab Share Price

BSE Share Price
Not Listed

Vardhaman Laboratories Ltd (524796)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524796 NSE: Pharmaceuticals & Drugs | Small Cap | Vardhaman Lab Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 1
TTM EPS
₹-0.1
TTM Sales
₹0 Cr.
Book Value per Share
₹4.8
P/E Ratio
0.00
Industry PE
46.6
Price to Book (P/B)
0.11
Price to Sales (P/S)
0.00
EV/EBITDA
9.33
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-1.98%
Return on Capital Employed (ROCE)
-1.98%
Return on Assets (ROA)
-1.96%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
37.20%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-2 Cr.
Equity
₹4.1 Cr.
Face Value
₹10
All Time Low / High
₹0.20 / 25.00

Vardhaman Laboratories stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
ROCE % ⓘ-8.3%-8.5%-2.4%12.9%-1.8%-1%-1.2%-1.5%-1.8%-2%-
Value Creation
Index ⓘ		-1.6-1.6-1.2-0.1-1.1-1.1-1.1-1.1-1.1-1.1-

Growth Parameters ⓘ
Sales ⓘ0.30.31.20.60000000
Sales YoY Gr.--15.6%359.3%-52.4%-100%NANANANANA-
Adj EPS ⓘ-0.6-0.6-0.30.2-0.2-0.1-0.1-0.1-0.1-0.1-0.1
YoY Gr.-NANANA-217.7%NANANANANA-
BVPS (₹) ⓘ6.35.14.95.55.25.25.154.94.94.8
Adj Net
Profit ⓘ		-0.3-0.2-0.10.1-0.1-0-0-0-0-0-0
Cash Flow from Ops. ⓘ0-0.10.4-1.8-0.10.10.3-0-00-
Debt/CF from Ops. ⓘ37.4-3.100000000-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-100%NANANA
Adj EPS ⓘNANANANA
BVPSⓘ-2.9%-1.5%-1.7%-1.8%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on
Equity % ⓘ		-9.5-9.9-6.63.4-3.8-1-1.2-1.5-1.8-2-1.2
Op. Profit
Mgn % ⓘ		-71.8-61.51.30.6000000NAN
Net Profit
Mgn % ⓘ		-81.9-86.1-1112.1000000-INF
Debt to
Equity ⓘ		0.10.200000000-
Working Cap
Days ⓘ		1,0691,1813281,1470000000
Cash Conv.
Cycle ⓘ		1,0351,102416890000000

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Sales0.320.271.240.59000000
Operating Expenses ⓘ + 0.540.441.220.590.030.040.050.080.070.08
Manufacturing Costs0.060.030.020.01000000
Material Costs0.240.171.010.51000000
Employee Cost 0.180.090.100.02000000
Other Costs ⓘ 0.050.140.090.060.030.040.050.080.070.08
Operating Profit ⓘ -0.23-0.170.020-0.03-0.04-0.05-0.08-0.07-0.08
Operating Profit Margin (%) -71.8%-61.5%1.3%0.6%------
Other Income ⓘ + 0.080.020.0100.010.020.030.050.040.04
Exceptional Items ⓘ 0000.29-0.0200000
Interest ⓘ 0.0100.0800.0100000
Depreciation ⓘ 0.100.080.080.02000000
Profit Before Tax ⓘ -0.26-0.23-0.140.27-0.04-0.02-0.03-0.03-0.04-0.04
Tax ⓘ 00000.0500000
Profit After Tax -0.26-0.23-0.140.27-0.10-0.02-0.03-0.03-0.04-0.04
PAT Margin (%) -81.9%-86.1%-11.0%46.0%------
Adjusted EPS (₹)-0.6-0.6-0.30.7-0.2-0.1-0.1-0.1-0.1-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Vardhaman Lab - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18

Equity and Liabilities

Shareholders Fund + 2.602.112.012.252.162.132.112.082.042
Share Capital ⓘ 4.124.124.124.124.124.124.124.124.124.12
Reserves ⓘ -1.52-2.01-2.12-1.87-1.97-1.99-2.02-2.05-2.09-2.13
Debt +0.320.3500000000
Long Term Debt0.320.3500000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables0.070.140.970000000.02
Others Liabilities ⓘ 00.010.1500.010.0100.020.010.01
Total Liabilities ⓘ 32.613.132.252.162.142.112.102.052.03

Fixed Assets

Net Fixed Assets ⓘ +2.091.631.590000000
Gross Block2.091.712.840000000
Accumulated Depreciation00.081.250000000
CWIP ⓘ 0000000000
Investments ⓘ 0.040.0400000000
Inventories0.630.680.180000000
Trade Receivables0.220.201.142.082.051.901.551.551.561.56
Cash Equivalents 0.010.040.200.170.110.230.540.530.480.43
Others Assets ⓘ 0.010.010.020000.020.010.010.05
Total Assets ⓘ 32.613.132.252.162.142.112.102.052.03

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Cash Flow From Operating Activity ⓘ + 0.01-0.120.44-1.75-0.060.130.31-0-0.040.02
PBT ⓘ -0.26-0.23-0.140.27-0.03-0.02-0.03-0.03-0.04-0.04
Adjustment ⓘ 0.110.080.15-0.27000000
Changes in Working Capital ⓘ 0.160.040.42-1.750.030.150.330.03-00.06
Tax Paid ⓘ 0000-0.0500000
Cash Flow From Investing Activity ⓘ + 0.0200.011.83000000
Capex -00-0.031.54000000
Net Investments 0.02-00.040000000
Others ⓘ 000.010.29000000
Cash Flow From Financing Activity ⓘ + -0.030.15-0.29-0.110000-0.01-0.08
Net Proceeds from Shares ⓘ 0000000000
Net Proceeds from Borrowing ⓘ 0000000000
Interest Paid ⓘ -0-0-0.08-0000000
Dividend Paid ⓘ 0000000000
Others ⓘ -0.020.15-0.21-0.110000-0.01-0.08
Net Cash Flow ⓘ 00.030.16-0.03-0.060.130.31-0-0.05-0.06

Financial Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Ratios
ROE (%)-9.46-9.91-6.5912.85-4.35-1.02-1.23-1.5-1.81-1.98
ROCE (%)-8.25-8.5-2.3812.86-1.75-1-1.22-1.47-1.76-1.98
Asset Turnover Ratio0.10.10.430.2000000
PAT to CFO Conversion(x)N/AN/AN/A-6.48N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days348.50285.30196.901,080.70000000
Inventory Days714.90887.50127.600000000
Payable Days74.70215.10200.10349.10000000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vardhaman Laboratories Ltd FAQs

The current trading price of Vardhaman Lab on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vardhaman Lab stood at ₹0.21 Cr

The latest P/E ratio of Vardhaman Lab as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Vardhaman Lab as of 31-Dec-1969 is 0.11.

The 52-week high of Vardhaman Lab is ₹0.66 and the 52-week low is ₹0.49.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vardhaman Lab is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Vardhaman Laboratories Ltd

Vardhaman Laboratories Limited was incorporated on April 24, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited and subsequently converted into a Public Limited vide special Resolution dated October 15, 1993 and obtained a fresh certificate of Incorporation to change of name on  December 7, 1993 as Vardhaman Laboratories Limited, from the registrar of Companies Maharashtra, Bombay.

At present the company is engaged in manufacturing varieties of formulations and marketing under the brand name of 'SAMRAT', gained sizable popularity in the area of Western Maharashtra and Southern part of India.

The company started its operation on a small scale basis and during this time was also in the process of identifying a viable project in the Pharmaceutical industry. After a thorough and exhaustive study, the project for manufacturing the Bulk Drugs as mentioned above was conceived in December 1993.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×